P2RY12 and COVID-19: Current users of ACEI, ARB, statin, warfarin, direct factor Xa inhibitors, P2Y12 inhibitors and famotidine were associated with 2–11% decreased risk of COVID-19 hospitalization when compared with never users (Table 3).